Trial update
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk: registry status update
The registry reports not yet recruiting. This is trial metadata, not an assessment of treatment benefit.